Found vs MEDVi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MEDVi beats Found overall, scoring 7.7/10 vs 7.3/10. Found is more affordable at $264/mo vs $299/mo. Choose Found for users who want a science-backed weight loss program with beh. Choose MEDVi for users who want a low entry price with oral and injectable co.
A side-by-side comparison of Found and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.
Found
#30 of 40Science-backed weight management platform combining GLP-1 medications with behavioral health coaching and support.
Visit FoundMEDVi
#21 of 40Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDVi| Feature | Found | MEDVi |
|---|---|---|
| Our Score | 7.3/10 | 7.7/10 |
| Starting Price | $264/mo | $299/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | Yes | No |
| Best For | Users who want a science-backed weight loss program with behavior change support | Users who want a low entry price with oral and injectable compounded options |
| Ranking | #30 | #21 |
Pros & Cons Compared
Found
Pros
- +Active insurance coordination — Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
- +10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill) — the widest formulary of any platform
- +Typical insured copay of ~$30/mo for most members — dramatically lower than cash-pay alternatives
- +Most members start treatment within one week of completing the health questionnaire
Cons
- −Pricing is less transparent than flat-rate competitors — costs vary by insurance status and medication choice
- −The insurance navigation process adds steps and complexity compared to simple cash-pay platforms
- −Compounded medication availability may shift with FDA enforcement changes
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
MEDVi edges out Found with a score of 7.7/10 vs 7.3/10. If budget is your priority, Found starts at $264/mo compared to MEDVi's $299/mo. Found accepts insurance, which can significantly reduce your out-of-pocket costs. Found offers both brand-name and compounded medications, giving you more flexibility. Choose Found if you want: users who want a science-backed weight loss program with behavior change support. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.